Diehl, A. M., Harrison, S., Caldwell, S., Rinella, M., Paredes, A., Moylan, C., … Abdelmalek, M. (2018). JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study. In Journal of Hepatology (Vol. 68, pp. S103–S103). Elsevier BV. https://doi.org/10.1016/s0168-8278(18)30425-2

Diehl, A. M., S. Harrison, S. Caldwell, M. Rinella, A. Paredes, C. Moylan, C. Guy, et al. “JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study.” In Journal of Hepatology, 68:S103–S103. Elsevier BV, 2018. https://doi.org/10.1016/s0168-8278(18)30425-2.

Diehl AM, Harrison S, Caldwell S, Rinella M, Paredes A, Moylan C, et al. JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study. In: Journal of Hepatology. Elsevier BV; 2018. p. S103–S103.

Diehl, A. M., et al. “JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study.” Journal of Hepatology, vol. 68, Elsevier BV, 2018, pp. S103–S103. Crossref, doi:10.1016/s0168-8278(18)30425-2.

Diehl AM, Harrison S, Caldwell S, Rinella M, Paredes A, Moylan C, Guy C, Bashir M, Wang Y, Miller L, Chang A, Sc Wu E, Abdelmalek M. JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study. Journal of Hepatology. Elsevier BV; 2018. p. S103–S103.